Tsuyoshi Yamashiro
Overview
Explore the profile of Tsuyoshi Yamashiro including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
307
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Higa F, Tateyama M, Tomishima M, Mukatake S, Yamashiro T, Owan T, et al.
Influenza Other Respir Viruses
. 2011 Nov;
6(4):299-303.
PMID: 22118572
Background: An influenza outbreak might result in disruption of services at acute care setting hospitals. Objectives: In this study, we retrospectively evaluated the use of neuraminidase inhibitor chemoprophylaxis for prevention...
3.
Higa F, Haranaga S, Tateyama M, Hibiya K, Yamashiro T, Nakamatsu M, et al.
Jpn J Infect Dis
. 2008 Sep;
61(5):371-4.
PMID: 18806344
This study comparatively evaluated the titers of the bacterial agglutination (BA) antibody for Bordetella pertussis, anti-pertussis toxin (PT) antibody, and anti-filamentous hemagglutinin (FHA) antibody in the serum of medical staff...
4.
Maeshiro T, Arakaki S, Watanabe T, Aoyama H, Shiroma J, Yamashiro T, et al.
World J Gastroenterol
. 2007 Aug;
13(34):4560-5.
PMID: 17729406
Aim: To investigate the different impact of genotypes B and C on the development of liver cirrhosis (LC) among different age groups of patients with chronic hepatitis B (CH-B). Methods:...
5.
Negative regulation of intracellular hepatitis C virus replication by interferon regulatory factor 3
Yamashiro T, Sakamoto N, Kurosaki M, Kanazawa N, Tanabe Y, Nakagawa M, et al.
J Gastroenterol
. 2006 Sep;
41(8):750-7.
PMID: 16988763
Background: Interferon regulatory factor (IRF)-3 plays an important role in initiating cellular interferon-stimulated gene-mediated antiviral responses. In the present study, we evaluated the effects of IRF-3 expression and activation on...
6.
Sakugawa H, Nakayoshi T, Kobashigawa K, Yamashiro T, Maeshiro T, Miyagi S, et al.
World J Gastroenterol
. 2005 Jan;
11(2):255-9.
PMID: 15633226
Aim: Nonalcoholic steatohepatitis (NASH) is a severe form of nonalcoholic fatty liver disease (NAFLD), and progresses to the end stage of liver disease. Biochemical markers of liver fibrosis are strongly...
7.
Sakugawa H, Yamashiro T, Maeshiro T
Nihon Naika Gakkai Zasshi
. 2004 Dec;
93(11):2351-6.
PMID: 15624471
No abstract available.
8.
Kanazawa N, Kurosaki M, Sakamoto N, Enomoto N, Itsui Y, Yamashiro T, et al.
J Virol
. 2004 Aug;
78(18):9713-20.
PMID: 15331704
Cellular antiviral responses are mediated partly by the expression of interferon-stimulated genes, triggered by viral genomes, their transcripts and replicative intermediates. Persistent replication of a hepatitis C virus (HCV) replicon...
9.
Sakugawa H, Nakayoshi T, Kobashigawa K, Nakasone H, Kawakami Y, Yamashiro T, et al.
World J Gastroenterol
. 2004 Mar;
10(7):1052-5.
PMID: 15052692
Aim: This study aimed to determine whether metabolic syndrome is directly or indirectly, through fatty liver, associated with elevated gamma-glutamyl transpeptidase (GGT) levels in Japanese women. Methods: From 4 366...
10.
Yamashiro T, Nagayama K, Enomoto N, Watanabe H, Miyagi T, Nakasone H, et al.
J Infect Dis
. 2004 Mar;
189(7):1151-7.
PMID: 15031781
Some hepatitis B virus (HBV) carriers with chronic hepatitis delta virus (HDV) superinfection show progressive chronic hepatitis, whereas others show no apparent signs of liver disease. In the present study,...